Datasheet is currently unavailable. Try again or CONTACT US
ERK1 N-Term Blocking Peptide
000-001-GP0
50 µg
Lyophilized
Shipping info:
$50.00 to US & $70.00 to Canada for most products. Final costs are calculated at checkout.
Product Details
ERK1 N-Term Blocking Peptide - 000-001-GP0
MAPK3, ERK, ERK1, PRKM3, ERK-1 Blocking peptide, ERK-1 Control peptide
Peptide
Target Details
MAPK3 - View All MAPK3 Products
Purity was determined to be greater than 95% specific peptide by analysis by HPLC and by reducing and non-reducing SDS-PAGE.
P27361 - UniProtKB
Application Details
ERK1 N-term blocking peptide is suitable as a control for polyclonal or monoclonal Anti-ERK1 in immunological assays.
Formulation
1.0 mg/mL by dry weight
None
0.01% (w/v) Sodium Azide
None
50µL
Restore with deionized water (or equivalent)
Shipping & Handling
Ambient
Store vial at 2-8 °C prior to opening. Aliquot contents and freeze at -20 °C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. Dilute only prior to immediate use.
Expiration date is six (6) months from date of receipt.
Mitogen activated protein kinase 3, also known as MAPK3, ERK, or ERK1, is an integral component of the MAP kinase cascade that regulates cell growth and differentiation. ERK1 and ERK2 are activated by MEK1 and MEK2 in the B-raf signaling pathway resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Human ERK1 and ERK2 are 84% identical in sequence and share common functionality in cells. ERK1 is ideal for investigators involved in Neuroscience, Cell Signaling and Cancer Research.
This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.
